» Related Searches: cancer, lung cancer, breast cancer, treatment, lung
… treatment of small cell lung cancer. The deal was worth $59M, along with two
additional payments of $12.... (more) … 
The National Institute for Health and Clinical Excellence has issued appraisal
consultation documents on Tarceva (erlotinib) and Alimat (pemetrexed) for the
treatment of non-small-cell lung cancer, recommending neither drug … 



Thousands of lung cancer sufferers are set to be denied the drug Tarceva, under draft
guidance from health watchdog … 



An innovative cancer drug has been turned down for use on the NHS, shortening the
lives of thousands of people who could benefit from it … 



Patients with metastatic cancer tumors in their lungs are much more likely to
live disease-free if they have an experimental treatment involving shaped-beam
radiosurgery rather that conventional treatment, according to … 



A new formulation of paclitaxel followed by carboplatin is showing promise in the
first-line treatment of advanced non?small-cell lung cancer. Medscape Medical
News Allison Gandey … 


